Fig. 2.
Actinic keratosis. Time course of mean composite LSR scores in phase III face/scalp studies of patients treated with ingenol mebutate 0.015%. LSR Local skin response
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.